Psychotic disorder and Clonus

Summary:

Clonus is found among people with Psychotic disorder, especially for people who are female, 60+ old.

The study analyzes which people have Clonus with Psychotic disorder. It is created by eHealthMe based on reports of 8 people who have Psychotic disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 21, 2023

8 people who have Psychotic Disorder and Clonus are studied.

What is Psychotic disorder?

Psychotic disorder is found to be associated with 1,993 drugs and 1,431 conditions by eHealthMe.

What is Clonus?

Clonus (series of involuntary, rhythmic, muscular contractions and relaxations) is found to be associated with 890 drugs and 551 conditions by eHealthMe.

Number of Clonus in Psychotic disorder reports submitted per year:

Would you have Clonus when you have Psychotic disorder?

Gender of people who have Psychotic Disorder and experienced Clonus *:

female: 100 %
male: 0.0 %

Age of people who have Psychotic Disorder and experienced Clonus *:

Common co-existing conditions for these people *:

High Blood Pressure: 3 people, 37.50%
Bipolar Disorder (mood disorder): 3 people, 37.50%
Hypokalemia (low potassium): 2 people, 25.00%
Depression: 2 people, 25.00%
Type 2 Diabetes: 1 person, 12.50%
Polymyalgia Rheumatica (pain in many muscles): 1 person, 12.50%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 12.50%
Dyslipidaemia (abnormal amount of lipids): 1 person, 12.50%

Common drugs taken by these people *:

Haldol: 2 people, 25.00%
Effexor: 2 people, 25.00%
Diclofenac: 1 person, 12.50%
Cymbalta: 1 person, 12.50%
Acetylsalicylic Acid: 1 person, 12.50%

Common symptoms for these people *:

Arrhythmias (irregular heartbeat): 5 people, 62.50%
High Blood Pressure: 3 people, 37.50%
Respiratory Distress (difficulty in breathing): 3 people, 37.50%
Consciousness - Decreased: 3 people, 37.50%
Nausea And Vomiting: 3 people, 37.50%
Hypophagia (reduced food intake): 2 people, 25.00%
Anuria (failure of the kidneys to produce urine): 2 people, 25.00%
Fever: 2 people, 25.00%
Depression: 2 people, 25.00%
Insomnia (sleeplessness): 2 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Clonus?

Check whether Clonus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

Related studies

Treatments, associated drugs and conditions:

Psychotic disorder (54,744 reports)
Clonus (2,852 reports)

COVID vaccines that are related to Clonus:

Common drugs associated with Clonus:

All the drugs that are associated with Clonus:

Clonus (890 drugs)

Common conditions associated with Clonus:

Depression: 318 reports
Pain: 144 reports

All the conditions that are associated with Clonus:

Clonus (551 conditions)

How the study uses the data?

The study is based on Clonus and Psychotic disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.